ACQUIRED GENERALISED LIPODYSTROPHY

ACQUIRED GENERALISED LIPODYSTROPHY was reported 13 times

ACQUIRED GENERALISED LIPODYSTROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Programmed Death Receptor-1 Blocking Antibody [EPC] 9 0.0001
1 Insulin [EPC] 1 0.0000
2 CTLA-4-directed Blocking Antibody [EPC] 1 0.0000
3 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
4 Aromatase Inhibitor [EPC] 1 0.0000
5 Microtubule Inhibitor [EPC] 1 0.0000
6 Alkylating Drug [EPC] 1 0.0000
7 GLP-1 Receptor Agonist [EPC] 1 0.0000
8 Insulin Analog [EPC] 1 0.0000
9 Kinase Inhibitor [EPC] 1 0.0000
10 Corticosteroid [EPC] 1 0.0000